Arterys said today that it raised a $12 million Series A round for the MR-based vascular imaging system it’s developing.
The San Francisco-based company said its system uses data from a 10-minute MRI chest scan to compute blood flow information with “deep learning” and artificial intelligence technology. Available to researchers now, the system is expected to be included in GE Healthcare MRI scanners this fall as part of the ViosWorks application, Arterys said.
Emergent Medical Partners led the round, joined by GE Ventures, the Stanford-StartX Fund and Norwich Ventures. Existing backers Asset Management Ventures, AME Cloud Ventures and Morado Ventures also participated, the company said.
The proceeds are earmarked for expanding the company’s commercial footprint.
“This financing includes premier organizations in the healthcare field who recognize the game-changing value of our solution to revolutionize medical imaging and improve patient care,” founder & CEO Fabien Beckers said in prepared remarks. “We plan to staff strategically as we expand our commercial presence both in the U.S. and Europe, while at the same time applying our medical imaging solutions beyond cardiac care in neurology and oncology.”
